Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Gotti M, Sciarra R, Pulsoni A, Merli F, Luminari S, Zerbi C, Trentin L, Re A, Rusconi C, Viviani S, Rossi A, Cocito F, Botto B, Meli E, Pinto A, Dogliotti I, Gini G, Puccini B, Ricci F, Nassi L, Fabbri A, Liberati AM, Merli M, Filippi AR, Bonfichi M, Zoboli V, Tartaglia G, Annechini G, D'Elia GM, Del Giudice I, Alvarez I, Visentin A, Pravato S, Dalceggio D, Pagani C, Ferrari S, Cristinelli C, Lazic T, Ferretti VV, Ricardi U, Arcaini L. Gotti M, et al. Among authors: re a. Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37034003 Free PMC article.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Tucci A, Merli F, Fabbri A, Marcheselli L, Pagani C, Puccini B, Marino D, Zanni M, Pennese E, Flenghi L, Arcari A, Botto B, Celli M, Mammi C, Re A, Campostrini G, Tafuri A, Zilioli VR, Cencini E, Sartori R, Bottelli C, Merli M, Petrucci L, Gini G, Balzarotti M, Cavallo F, Musuraca G, Luminari S, Rossi G, Spina M. Tucci A, et al. Among authors: re a. Haematologica. 2023 Apr 1;108(4):1083-1091. doi: 10.3324/haematol.2022.281407. Haematologica. 2023. PMID: 36384247 Free PMC article.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Ferrero S, Grimaldi D, Arrigoni E, Pironti M, Zaccaria GM, Alessandria B, Genuardi E, De Luca G, Ghislieri M, Tavarozzi R, Di Rocco A, Re A, Stefoni V, Cavallo F, Boccomini C, Balzarotti M, Zilioli V, Moita F, Arcaini L, Lucchini E, Ballerini F, Ferreri AJM, Puccini B, Palumbo GA, Galimberti S, Cortelazzo S, Di Paolo A, Ladetto M. Ferrero S, et al. Among authors: re a. Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504. Blood Adv. 2023. PMID: 37058477 Free PMC article. Clinical Trial.
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.
Tisi MC, Moia R, Patti C, Evangelista A, Ferrero S, Spina M, Tani M, Botto B, Celli M, Puccini B, Cencini E, Di Rocco A, Chini C, Ghiggi C, Zambello R, Zanni M, Sciarra R, Bruna R, Ferrante M, Pileri SA, Quaglia FM, Stelitano C, Re A, Volpetti S, Zilioli VR, Arcari A, Merli F, Visco C. Tisi MC, et al. Among authors: re a. Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744. Blood Adv. 2023. PMID: 37171620 Free PMC article.
Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana Linfomi.
Cavallo F, Clerico M, Lucchini E, Castiglione A, Re A, Zilioli VR, Visco C, Tani M, Olivieri J, Arcaini L, Fabbri A, Gaidano G, Dodero A, Zaja F. Cavallo F, et al. Among authors: re a. Br J Haematol. 2024 Oct;205(4):1404-1410. doi: 10.1111/bjh.19617. Epub 2024 Jun 28. Br J Haematol. 2024. PMID: 38938122 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 39112200
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review.
Accorsi Buttini E, Farina M, Lorenzi L, Polverelli N, Radici V, Morello E, Colnaghi F, Almici C, Ferrari E, Bianchetti A, Leoni A, Re F, Bosio K, Bernardi S, Malagola M, Re A, Russo D. Accorsi Buttini E, et al. Among authors: re a, re f. Front Oncol. 2023 Jan 20;13:1036455. doi: 10.3389/fonc.2023.1036455. eCollection 2023. Front Oncol. 2023. PMID: 36741006 Free PMC article.
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report.
Radici V, Giagulli C, Accorsi Buttini E, Farina M, Polverelli N, Brugnoni D, Chiarini M, Galvagni A, Almici C, Ferrari E, Bianchetti A, Masneri S, Leoni A, Re F, Bernardi S, Malagola M, Re A, Caruso A, Russo D. Radici V, et al. Among authors: re a, re f. Front Transplant. 2023 Sep 19;2:1238494. doi: 10.3389/frtra.2023.1238494. eCollection 2023. Front Transplant. 2023. PMID: 38993894 Free PMC article.
Effect of Vitamin D and Docosahexaenoic Acid Co-Supplementation on Vitamin D Status, Body Composition, and Metabolic Markers in Obese Children: A Randomized, Double Blind, Controlled Study.
De Cosmi V, Mazzocchi A, D'Oria V, Re A, Spolidoro GCI, Milani GP, Berti C, Scaglioni S, Giavoli C, Bergamaschi S, Rodari G, Profka E, Colombo R, Agostoni C. De Cosmi V, et al. Among authors: re a. Nutrients. 2022 Mar 27;14(7):1397. doi: 10.3390/nu14071397. Nutrients. 2022. PMID: 35406010 Free PMC article. Clinical Trial.
522 results